Libenzapril

CAS No. 109214-55-3

Libenzapril( —— )

Catalog No. M34314 CAS No. 109214-55-3

Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 380 Get Quote
5MG 592 Get Quote
10MG 843 Get Quote
25MG 1224 Get Quote
50MG 1638 Get Quote
100MG 2187 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Libenzapril
  • Note
    Research use only, not for human use.
  • Brief Description
    Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
  • Description
    Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    ACE
  • Recptor
    Angiotensin-converting Enzyme (ACE)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109214-55-3
  • Formula Weight
    363.41
  • Molecular Formula
    C18H25N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(O)=O)N1C=2C(CC[C@H](N[C@@H](CCCCN)C(O)=O)C1=O)=CC=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Zabicipril HCl

    Zabicipril HCl(S 9650) is a potent angiotensin-converting enzyme inhibitor.

  • Lisinopril dihydrate

    A angiotensin-converting enzyme (ACE) inhibitor for treatment of hypertension, heart failure, and after heart attacks.

  • Libenzapril

    Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.